The lack of health data on LGBTQ+ people has significant consequences, as evidenced by struggles to receive appropriate care for conditions more prevalent in transgender women. Social and structural stigma contribute to disparities in healthcare access, insurance coverage, risk factors, and mental health challenges within the LGBTQ+ community. Calls for increased collection of LGBTQ+ health data have been made by various entities, including the pharmaceutical industry. The collection of sexual orientation, gender identity, and intersex status data in clinical trials is crucial for understanding and addressing disparities in healthcare outcomes for LGBTQ+ patients. Collaboration across healthcare stakeholders is essential to achieve equitable health outcomes.
Source link
Lack of health data on LGBTQ+ people has serious consequences
